Sidley Austin LLP and Maples Group advised Sunac; Linklaters acted for the group of bondholders and lenders. Sunac China Holdings Limited (Sunac) completed the restructuring of its...
Sunac China’s $10.2 Billion Offshore Debt Restructuring
Cellomics’ Series B+ Financing Round
Sidley represented Cellomics on the financing. Cellomics announced its Series B+ financing. The lead investor is an equity fund of a Hong Kong-listed insurance company. The...
TMF Group’s Acquisition of Sino Corporate Services Group
Sidley represented TMF Group on the deal. TMF Group announced its acquisition of Sino Corporate Services Group, a provider of fund, trust, and corporate services located...
Gala Technology’s Hong Kong IPO
Sidley represented Gala Technology Holding Limited on the deal. Gala Technology Holding Limited (HKEX: 2458) (Gala Technology) acted as Hong Kong counsel in its initial public...
Cellomics’ Series B financing
Sidley Austin advised Cellomics on the deal. Cellomics, a leading Hong Kong-based biotech company focusing on development and commercialization of liquid biopsy products for cancer screening...